I started working in cancer research in 2014 at Virginia Commonwealth University’s Massey Cancer Center, working in a translational lab finding therapies for adult hematologic malignancies. In 2017, I moved to Atlanta’s Emory University, working in a lab developing a tyrosine kinase inhibitor, now in clinical trials, for use in pediatric malignancies and lung cancer. In 2019, I joined Emory’s Cancer Biology graduate program where my research focuses on the basic biology of KRAS/LKB1-mutant lung cancer, with the goal of finding exploitable vulnerabilities to improve treatment of this aggressive disease.